ValGenesis announced a New Jersey-based leading contract manufacturer of pharmaceutical drugs has chosen ValGenesis's 100% paperless VLMS to manage its validation lifecycle process.
Serving the North American market, this manufacturer is focused on acquiring, developing, manufacturing and marketing high quality, niche generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories to fulfill specific patient needs. The company offers products in various formulations, such as suspensions, emulsions/foams, topical gels, creams and suppositories.
ValGenesis Enterprise VLMS will reduce validation cycle time, gain a higher standard of data integrity, improve regulatory compliance, and gain a holistic view of real-time validation statuses across its regulated systems, thereby improving the quality and speed of the entire process.
"ValGenesis is excited to be selected as the right tool to help with automating their computer system validation process," said Narayan Raj, Vice President of ValGenesis Inc. "Our VLMS is an ideal solution for companies like this, interested in reducing overall validation time while realizing significant cost savings. Now these companies can focus on what they do best, being a trusted contract manufacturer that delivers quality pharmaceutical drugs."